삼일제약(주) · KOSPI: 000520 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩196.3B | ₩219.7B | ₩210.3B |
| Operating income | ₩6.5B | ₩113M | −₩22.2B |
| Net income | ₩1.7B | −₩5.6B | −₩34.7B |
| Total assets | ₩370.7B | ₩395.1B | ₩371.6B |
| Total liabilities | ₩242.9B | ₩218.9B | ₩238.3B |
| Total equity | ₩127.8B | ₩176.1B | ₩133.3B |
| Share capital | ₩7.6B | ₩10.8B | ₩10.8B |
Consolidated statements · FY2025 operating margin -10.6% · liabilities to equity 179% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 73 (current) | 우리회계법인 | Unqualified |
| Term 72 (prior) | 우리회계법인 | Unqualified |
| Term 71 (two years prior) | 한영회계법인 | Unqualified |
| Date | Largest shareholder (Korean) | Stake | Cause (Korean) |
|---|---|---|---|
| 2023년 03월 27일 | 허승범 외 9인 | — | 무상증자 |
| 2025년 02월 24일 | 허승범 외 10인 | — | 장내매매 |
| 2025년 02월 27일 | 허승범 외 10인 | — | 장내매매 |
| 2025년 04월 04일 | 허승범 외 10인 | — | 장내매매 |
| 2025년 04월 08일 | 허승범 외 10인 | — | 장내매매 |
| 2025년 05월 15일 | 허승범 외 10인 | — | 장내매매 |
| 2025년 10월 23일 | 허승범 외 10인 | — | 장내매매 |
| 2025년 12월 31일 | 허승범 외 10인 | — | 장내매매 |
| 2023년 06월 19일 | 허승범 외 9인 | — | 장내매매 |
| 2023년 07월 06일 | 허승범 외 9인 | — | 장내매매 |
| Date | Filing | Original |
|---|---|---|
| 2026-08-14 | Half-year report (2026.06) | DART |
| 2026-07-21 | Large shareholding (5%+) report | DART |
| 2026-07-01 | Officer / major shareholder ownership report | DART |
| 2026-06-19 | Results of share or equity-linked bond issuance (voluntary) | DART |
| 2026-06-11 | Officer / major shareholder ownership report | DART |
| 2026-06-11 | Material event report — Convertible bond issuance decision | DART |
| 2026-06-08 | Change in shareholdings of largest shareholder | DART |
| 2026-06-05 | Officer / major shareholder ownership report | DART |
| 2026-06-02 | Change in shareholdings of largest shareholder | DART |
| 2026-06-01 | Officer / major shareholder ownership report | DART |
| 2026-06-01 | Officer / major shareholder ownership report | DART |
| 2026-05-29 | Corporate governance report | DART |
| 2026-05-22 | Change in shareholdings of largest shareholder | DART |
| 2026-05-22 | Officer / major shareholder ownership report | DART |
| 2026-05-20 | Change in shareholdings of largest shareholder | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-05-06 | Officer / major shareholder ownership report | DART |
| 2026-05-06 | Change in shareholdings of largest shareholder | DART |
| 2026-04-30 | Change in shareholdings of largest shareholder | DART |
| 2026-04-23 | Large shareholding (5%+) report | DART |
Showing the 20 most recent of 43 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.